Member Info for Zoom0001

They have the remainder of the raise, DHSC payment and believe it or not, they do receive some revenue. Funded long enough to get their ducks in a row so pointless talking about a fundraise as you well know.

They could easily raise at a discount to todays price if required. That’s the whole point of this market.

Anyway, talk of placings not necessary. You know full well they are well funded.

My view on the valuation is failure to secure production orders in volume...yet and trust issues with management.

DHSC contract cancelled and not RNS'D
Avacta Affidx paused just after the fundraise. Some may view this as a bit too convenient.

Things to look forward to.

2.7 Million high margin LFT deal. Tech transfer guidance within 2 months. We are beyond this now so hopefully any day.
Vatic FDA EUA approval although this has gone remarkably quiet, no further communication from Abingdon or Vatic since tech transfer completion. Market clearly unnerved by this.
Taiwan - potential for a substantial revolving order subject to EUA (again). Initial RNS was pointless in my view without anticipated timescales.
A host of collaborations for tests - again no timescales offered.
Simplytest will hopefully gain traction.

Potentially very exciting times ahead but beyond frustrating currently. Funding isn't an issue short term. They need to get something over the line for this to take off and quickly.

Who knows what’s happening. Abingdon haven’t Tweeted anything since July 7th. Nothing from Vatic since May. Absolutely no positive sentiment here at the moment but it could change wit a single news item. Just wish they would hurry up before we’re worth nothing. Abingdon have created a nightmare for their original investor base.

To be fair to them, they’re good at Technical transfer. Approvals for their customers seems to be the stumbling block. Everything takes around a hundred years longer than expected. Disappointed with Vatic silence. Don’t think they should have bothered with the Taiwan RNS until approved. The Tech transfer for the 2.7 million deal is due now. Let’s hope they at least get this done in a timely fashion.

I’m convinced anyone sticking money into Abingdon at these levels will be considerably better of in a few weeks time. I think we’re close to some form of news. Abingdon are extremely quiet on all fronts this week.

I’ve been watching some absolute dog stocks go ballistic this week, some on nothing but thin air and no income for the foreseeable. I’m really struggling to understand the lack of interest here with the pipeline of projects. It’s like the market is having none of it.

A decent contract at manufacturing stage. They just need to get something over the line and I’m sure this will move significantly.

BA 2.75 staring to get coverage. Come on Abingdon!

Yes of course. Everything’s spot on hence the sub 10p valuation. I’m not a doom monger and have a rather large holding here. Your last post about (it must be manipulation) sums it up really. It’s ok to talk about the good and bad. Something clearly is either being missed by the market or does not stack up.

* we’ve, you’ve.

Shame we you’ve had to resort to digging around in Linked to try and establish what’s going on. I guess Abingdon aren’t required to say anything. Frustrating times.

We had a sneak preview of the e-commerce site recently courtesy of Muck165. It didn’t look far off to me although they could be waiting for further product validation prior to launch.

Thanks Pokerchips. It would be good to know for sure.

Aren’t the DHSC pursuing them for more than their MCAP?

6.3 million less 1.5 million subject to the court case outcome. It came to light yesterday that consortium members are outstanding payments from Abingdon and I there was quite a substantial VAT reversal which will now need to be paid. Happy to be corrected.

Yes I agree but it’s being fuelled by Abingdon’s lack of clarity with their communication. I genuinely have no idea what last news items mean to the company in terms of timing and cash flow.

Makes you realise how little the market knows about AVCT. In HD2U’s defence, if your knowledge of AVCT is via Abingdon’s communications then he’s not wrong on the LFT front. Obviously AVCT have a great deal more going on.

Agree. The RNS is a bit disingenuous. The management really don’t fill me with confidence.

The monies received from DHSC, once received, will provide additional working capital and be deployed to help fund the Company's various growth initiatives underway.

The best chance of a meaningful step up here will be when they announce they are manufacturing at scale.